Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Sell
19
STOK Quote, Financials, Valuation and Earnings
Last price:
$7.04
Seasonality move
:
-2.4%
Day range:
$6.42 - $7.13
52-week range:
$5.35 - $17.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.34x
P/B ratio:
1.66x
Volume:
731.1K
Avg. volume:
920.5K
1-year change:
-48%
Market cap:
$379.6M
Revenue:
$36.6M
EPS (TTM):
-$1.68
Earnings Data
Next earnings date for STOK
May 06
2025
Most recent earnings per share
-$0.18
Beat by $0.35
(Mar 18/2025)
Consensus Estimate
-$0.53
(Mar 18/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
STOK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $31.3M | -- | -- | -$0.03 | -- |
| 05/06/2025 | Q1 | $29.8M | -- | -- | -$0.12 | -- |
| 03/18/2025 | Q4 | $4.3M | $22.6M | -$0.18 | -$0.53 | $0.35 |
| 11/05/2024 | Q3 | $3.6M | $4.9M | -$0.47 | -$0.54 | $0.07 |
| 08/07/2024 | Q2 | $3.3M | $4.8M | -$0.46 | -$0.56 | $0.10 |
| 05/06/2024 | Q1 | $3.2M | $4.2M | -$0.57 | -$0.61 | $0.04 |
| 03/25/2024 | Q4 | $3.2M | $2.8M | -$0.60 | -$0.63 | $0.03 |
| 11/07/2023 | Q3 | -- | -- | -$0.55 | -$0.65 | $0.10 |
| 08/07/2023 | Q2 | -- | -- | -$0.69 | -$0.66 | -$0.03 |
| 05/04/2023 | Q1 | -- | -- | -$0.53 | -$0.72 | $0.19 |
| 03/10/2023 | Q4 | -- | -- | -$0.65 | -$0.71 | $0.06 |
| 11/14/2022 | Q3 | -- | -- | -$0.66 | -$0.68 | $0.02 |
| 08/08/2022 | Q2 | -- | -- | -$0.63 | -$0.69 | $0.06 |
| 05/10/2022 | Q1 | -- | -- | -$0.66 | $0.13 | -$0.79 |
| 03/10/2022 | Q4 | -- | -- | -$0.66 | -$0.61 | -$0.05 |
| 11/08/2021 | Q3 | -- | -- | -$0.61 | -$0.55 | -$0.06 |
| 08/10/2021 | Q2 | -- | -- | -$0.60 | -$0.46 | -$0.14 |
| 05/10/2021 | Q1 | -- | -- | -$0.46 | -$0.44 | -$0.02 |
| 03/09/2021 | Q4 | -- | -- | -$0.42 | -$0.42 | $0.00 |
| 11/12/2020 | Q3 | -- | -- | -$0.41 | -$0.43 | $0.02 |
| 08/10/2020 | Q2 | -- | -- | -$0.39 | -$0.36 | -$0.03 |
| 05/15/2020 | Q1 | -- | -- | -$0.34 | -$0.37 | $0.03 |
| 03/23/2020 | Q4 | -- | -- | -$0.31 | -$0.30 | -$0.01 |
| 11/12/2019 | Q3 | -- | -- | -$0.26 | -$0.28 | $0.02 |
| 08/14/2019 | Q2 | -- | -- | -$1.54 | -$1.63 | $0.09 |
Stoke Therapeutics Earnings Questions
-
How Much did Stoke Therapeutics Generate in Revenue Last Quarter?
Stoke Therapeutics reported $22.6M worth of top line sales in its most recent quarter.
-
Did Stoke Therapeutics Beat Earnings Last Quarter?
Stoke Therapeutics announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.53 per share.
-
Is Stoke Therapeutics Profitable?
Stoke Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Stoke Therapeutics EPS Next Year?
Stoke Therapeutics's earnings are forecast to decrease from -$1.65 per share to -$1.34 per share next year representing a decrease of -16.63%.
-
When is Stoke Therapeutics's Earnings Date?
Stoke Therapeutics's next earnings date is May 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
